Clinical Trial Update: ADOPT: Improving Diagnosis of Pulmonary Hypertension With AI and Echo

View source ↗

Summary

The ADOPT trial, exploring AI and echocardiography to improve diagnosis of pulmonary hypertension, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: Royal United Hospitals Bath NHS Foundation Trust | Conditions: Pulmonary Hypertension | Status: WITHDRAWN